La cadena de opciones muestra datos clave de las opciones de acciones de Ashland a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Ashland..

Ashland (NYSE:ASH) Bolsa, Cadena de Opciones

Ashland

Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. Ashland includes only U.S. and Canada in its North America designation and includes Europe, the Middle East and Africa in its Europe designation.

Ashland Global Holdings

Ashland Inc

Ashtrom Group Ltd

ASBERRY 22 HLDGS INC by ASBERRY 22 HLDGS INC.

Asberry 22 Holdings Inc

ASHLEY SVCS GROUP LTD by ASHLEY SVCS GROUP LTD.

Ashley Services Group Ltd

Xtrackers Harvest CSI 300 China A-Shares ETF

X HARVEST CSI300 INDEX UCITS (DR) ETF

XTRCKR HRVST CSI 300 CHNA A SHR ETF

Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF

Ashtead Group PLC

ASHTEAD GROUP ORD

ASHTED GRP PLC UNSP/ADR by Ashtead Group PLC

DBX ETF Trust Xtrackers MSCI China A Inclusion Equity ETF

PROGRESSIVE PLANET NEW by Progressive Planet Solutions Inc.

Progressive Planet Solutions Inc

Ashland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) is gearing up to announce its quarterly earnings on Wednesday, 2024-11-06. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Ashland will report an earnings per share (EPS) of $1.28.
Ashland bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Overview of Past Earnings</h3>
During the last quarter, the company reported an EPS beat by $0.06, leading to a 9.57% drop in the share price on the subsequent day.
Here's a look at Ashland's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.43</td>
<td>1.14</td>
<td>0.19</td>
<td>0.63</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.49</td>
<td>1.27</td>
<td>0.45</td>
<td>0.41</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-10.0%</td>
<td>-1.0%</td>
<td>16.0%</td>
<td>-5.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730826170_0.png" alt="eps graph" />
<h3>Performance of Ashland Shares</h3>
Shares of Ashland were trading at $85.32 as of November 04. Over the last 52-week period, shares are up 11.05%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<a href="https://www.benzinga.com/quote/ASH/earnings">To track all earnings releases for Ashland visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

Exploring Ashland's Earnings Expectations

Ratings for Ashland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $97.0, a high estimate of $107.00, and a low estimate of $89.00. Experiencing a 8.27% decline, the current average is now lower than the previous average price target of $105.75. 
<img src="https://www.benzinga.com/files/images/story/2024/1723741227_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The analysis of recent analyst actions sheds light on the perception of Ashland by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$107.00</td>
<td>$116.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$92.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$100.00</td>
<td>$112.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$89.00</td>
<td>$90.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Ashland. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Ashland compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Ashland's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Ashland's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ASH/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Ashland analyst ratings.</a>
<h2>About Ashland</h2>
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. Ashland includes only U.S. and Canada in its North America designation and includes Europe, the Middle East and Africa in its Europe designation.
<h3>Financial Insights: Ashland</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Ashland's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately -0.37%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 1.1%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Ashland's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 0.2%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Ashland's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.1%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Ashland's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.49.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Analyst Scoreboard: 4 Ratings For Ashland

UBS analyst Joshua Spector maintains Ashland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) with a Buy and lowers the price target from $116 to $107.

News

Price Target

UBS Maintains Buy on Ashland, Lowers Price Target to $107

ArcelorMittal&nbsp;S.A.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mt#NYSE">MT</a>) recently completed the acquisition of 65,243,206 shares, representing approximately 28.4% equity interest in Vallourec. This follows the signing of a Share Purchase Agreement on Mar 12, 2024, and the subsequent approval from relevant antitrust authorities and clearances under foreign investment regulations. The shares were acquired at &euro;14.64 per share from funds managed by Apollo Global Management Inc for a total consideration of approximately &euro;955 million (roughly $1,043 million), subject to the successful completion of the settlement.
Following the completion of the transaction, Genuino Magalhaes Christino, chief financial officer of ArcelorMittal, will become the director of Vallourec. Keith Howell, chief operating officer of ArcelorMittal USA, will be appointed as a director of Vallourec as well. Aditya Mittal will take on the role of observer, subject to the successful settlement.
ArcelorMittal stated that it does not intend to launch a tender offer for the remaining shares of Vallourec over the next six months but will inform the market if this intention changes.
In its comments on the acquisition, ArcelorMittal emphasized Vallourec&#39;s strong position as a leading producer of high-quality tubular products within a market segment poised for growth, mainly driven by emerging clean energy markets. The company highlighted the strategic stake in Vallourec as a valuable addition to its investment portfolio and expressed its commitment to supporting Vallourec&#39;s management team in their efforts to enhance performance.
MT underscored that this acquisition aligns with its broader growth strategy. The company noted that recent acquisitions in Brazil and the United States are delivering strong results. Significant progress is being made on various organic growth projects, many of which are expected to reach completion this year. These initiatives are anticipated to considerably bolster MT&#39;s business by expanding product capabilities, increasing exposure to emerging markets and enhancing overall earnings capacity.
The stock has lost 18.9% in the past year against the&nbsp;industry&#39;s&nbsp;18.6% fall.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/ee/73994.jpg?v=931722439" />
Image Source: Zacks Investment Research
In second-quarter earnings call, the company revised its projection for global steel consumption growth, excluding China, to 2.5-3% for 2024, down from its previous estimate of 3-4%. The company continues to forecast capital expenditures for 2024 within the range of $4.5-$5 billion, with $1.4-$1.5 billion allocated to strategic growth projects. The company expects a $1.6 billion-investment in working capital made in the first half of 2024 to reverse by the year-end, supporting a positive outlook for free cash-flow generation. Completing strategic growth projects is anticipated to lead to structurally higher EBITDA and investable cash flow in the future.
<div class="chart_embed">
<h3>ArcelorMittal Price and Consensus</h3>
<img alt="ArcelorMittal Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/7a/1723462652.png" style="height:265px; width:582px" title="" />
ArcelorMittal price-consensus-chart | ArcelorMittal Quote
</div>
<h3>Zacks Rank &amp; Key Picks</h3>
ArcelorMittal currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Newmont Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nem#NYSE">NEM</a>), Franco-Nevada Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fnv#NYSE">FNV</a>) and Ashland Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ash#NYSE">ASH</a>). Newmont and Franco-Nevada sport a Zacks Rank #1 (Strong Buy), and Ashland currently carries a Zacks Rank #2 (Buy).
The Zacks Consensus Estimate for Newmont&#39;s current-year earnings is pegged at $2.82, indicating a rise of 75% from year-ago levels. The consensus estimate for NEM&#39;s earnings has increased 16% in the past 60 days.The stock has gained nearly 20.9% in the past year.
The Zacks Consensus Estimate for FNV&#39;s current-year earnings is pegged at $3.27. The consensus estimate for FNV&#39;s earnings has increased by 3% in the past 60 days. FNV beat the consensus estimate in the last four quarters, with the average earnings surprise being 10.5%.
The Zacks Consensus Estimate for ASH&#39;s current fiscal year earnings is pegged at $4.6, indicating a year-over-year rise of 13%. ASH&#39;s earnings beat the Zacks Consensus Estimate in three of the last four quarters while missing it once, the average earnings surprise being 27.4%. The company&#39;s shares have increased 5.4% in the past year.
<a href="https://www.zacks.com/stock/news/2320862/arcelormittal-mt-closes-strategic-28-stake-buy-in-vallourec?cid=CS-BENZ-FT-analyst_blog|company_news_corporate_actions-2320862">To read this article on Zacks.com click here.</a>

Earnings Beats

Large Cap

Buybacks

Markets

Trading Ideas

ArcelorMittal Closes Strategic 28% Stake Buy in Vallourec

BMO Capital analyst John McNulty maintains Ashland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) with a Market Perform and lowers the price target from $105 to $92.

BMO Capital Maintains Market Perform on Ashland, Lowers Price Target to $92

Wells Fargo analyst Michael Sison maintains Ashland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) with a Overweight and lowers the price target from $112 to $100.

Wells Fargo Maintains Overweight on Ashland, Lowers Price Target to $100

JP Morgan analyst Jeffrey Zekauskas upgrades Ashland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) from Underweight to Neutral and lowers the price target from $90 to $89.

Upgrades

JP Morgan Upgrades Ashland to Neutral, Lowers Price Target to $89

U.S. stock futures were higher this morning, with the Dow futures gaining around 300 points on Wednesday.
Shares of Airbnb, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) dipped 15.8% to $109.68 after the company reported worse-than-expected second-quarter EPS results and issued third-quarter revenue <a href="https://www.benzinga.com/markets/equities/24/08/40213199/why-airbnb-stock-is-down-16-in-wednesday-pre-market">guidance below estimates</a>.
Airbnb's second-quarter sales of $2.748 billion exceeded the analyst consensus estimate of $2.738 billion, marking a 10.63% increase from the same period last year. However, the company's quarterly GAAP earnings of 86 cents per share fell short of the analyst consensus estimate of 92 cents, missing the mark by 6.52%.
ZoomInfo Technologies shares dipped 15.2% to $8.31 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Emergent BioSolutions Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) shares dipped 36.2% to $6.27 in pre-market trading after posting a loss for the second quarter.</li>
<li>Nevro Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVRO#NYSE">NVRO</a>) shares declined 31.1% to $5.99 in pre-market trading after the company reported worse-than-expected second-quarter sales results.</li>
<li>National Vision Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYE#NASDAQ">EYE</a>) dipped 24.8% to $10.50 in pre-market trading following weak quarterly sales.</li>
<li>Cryoport, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYRX#NASDAQ">CYRX</a>) shares slipped 23.5% to $5.95 in pre-market trading after posting weak quarterly sales.</li>
<li>The RealReal, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REAL#NASDAQ">REAL</a>) dipped 19.4% to $2.50 in pre-market trading following second-quarter results.</li>
<li>Trex Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TREX#NYSE">TREX</a>) fell 16.7% to $63.75 in pre-market trading after the company reported worse-than-expected second-quarter sales results.</li>
<li>ACADIA Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACAD#NASDAQ">ACAD</a>) dipped 16.7% to $15.70 following second-quarter results.</li>
<li>Progyny, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGNY#NASDAQ">PGNY</a>) fell 16.5% to $21.48 in pre-market trading after the company reported worse-than-expected second-quarter revenue results.</li>
<li>Tripadvisor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIP#NASDAQ">TRIP</a>) fell 15.4% to $13.80 in pre-market trading after the company reported worse-than-expected second-quarter sales results.</li>
<li>Lyft, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) shares declined 14.2% to $9.41 following second-quarter financial results.</li>
<li>Rivian Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) dipped 8.1% to $13.60 after the company reported worse-than-expected quarterly adjusted EPS results.</li>
<li>Ashland Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) dipped 6.2% to $84.78 following weak quarterly sales.</li>
<li>Expedia Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) fell 3.8% to $113.05.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40194186/top-4-materials-stocks-which-could-rescue-your-portfolio-this-month">Top 4 Materials Stocks Which Could Rescue Your Portfolio This Month</a></li>
</ul>

Pre-Market Outlook

Movers

ABNB

ACAD

CYRX

EXPE

LYFT

NVRO

PGNY

REAL

RIVN

TREX

TRIP

Airbnb Reports Weak Earnings, Joins Cryoport, Tripadvisor, Lyft And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Ashland To Sell Nutraceuticals Business To Turnspire Capital&nbsp;
Planning For Choppy Demand Environment While Advancing Long-Term Growth Strategies

Guidance

Ashland Sees Fiscal Q4 Sales Of $530M-$540M And Adjusted EBITDA Of $130M-$140M; FY Sales Projected At $2.1B With Adjusted EBITDA Of $465M-$475M; Continues Reducing Inventory And Lower Value Business Exposure; Significant Year-Over-Year Margin Improvement Expected; Anticipates Mid-Single-Digit Volume Growth In Q4, Offset By Low-Single-Digit Pricing Declines

Ashland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) reported quarterly earnings of $1.49 per share which beat the analyst consensus estimate of $1.45 by 2.76 percent. The company reported quarterly sales of $544.00 million which missed the analyst consensus estimate of $574.73 million by 5.35 percent. This is a 0.37 percent decrease over sales of $546.00 million the same period last year.

Earnings Misses

Ashland Q3 2024 Adj EPS $1.49 Beats $1.45 Estimate, Sales $544.00M Miss $574.73M Estimate

United States Steel Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/x#NYSE">X</a>) logged a profit of $183 million or 72 cents per share for second-quarter 2024, down from a profit of $477 million or $1.89 per share in the year-ago quarter.
Barring one-time items, adjusted earnings per share were 84 cents, down from $1.92 a year ago. The figure, however, topped the Zacks Consensus Estimate of 76 cents.
Revenues fell around 18% year over year to $4,118 million in the reported quarter. The figure, however, surpassed the Zacks Consensus Estimate of $3,998.2 million.
The company reported a total shipment of 3,591,000 tons for the reported quarter, down around 9% year over year. It was below our estimate of 3,744,000 tons. The company faced pricing headwinds across its segments during the reported quarter.
<div class="chart_embed">
<h3>United States Steel Corporation Price, Consensus and EPS Surprise</h3>
<img alt="United States Steel Corporation Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/ea/1722591063.png" style="height:265px; width:576px" title="" />
United States Steel Corporation price-consensus-eps-surprise-chart | United States Steel Corporation Quote
</div>
<h3>Segment Highlights</h3>
Flat-Rolled: The segment recorded a profit of $183 million in the reported quarter, down around 21% from the year-ago quarter.
Steel shipments in the segment went down roughly 9% year over year to 2,045,000 tons. The average realized price per ton in the unit was $1,051, down around 3% year over year. It was below our estimate of $1,056.
Mini Mill: The segment recorded a profit of $28 million in the quarter, down around 79% year over year. Shipments were 562,000 tons, down around 4% year over year. The average realized price per ton was $869, down around 14% year over year. It was above our estimate of $798.
U.S. Steel Europe: The segment posted a loss of $10 million in the reported quarter. This compares to a profit of $72 million a year ago. Shipments fell roughly 15% year over year to 875,000 tons. The average realized price per ton for the unit was $821, down around 15% year over year. It was below our estimate of $829.
Tubular:&nbsp; The segment posted a profit of $29 million in the reported quarter, down roughly 82% year over year. Shipments fell roughly 2% to 109,000 tons. The average realized price per ton for the unit was $2,108, down nearly 40% year over year. It was above our estimate of $2,004.
<h3>Financials</h3>
At the end of the quarter, the company&#39;s cash and cash equivalents were $2,031 million, down around 9% from the previous quarter&#39;s levels. Long-term debt was $4,078 million, flat sequentially.
<h3>Outlook</h3>
Moving ahead, X expects adjusted EBITDA for the third quarter in the band of $275-$325 million factoring in recent pricing dynamics, which continues to impact its business. It expects the results in the North American Flat-Rolled segment to soften modestly as reduced spot prices more than offset continued strength in contract order book and lower spending. In the Mini Mill segment, X sees results to reflect lower spot prices and $30 million of associated start-up and one-time construction costs ahead of the planned start-up of Big River 2 in the fourth quarter.
The results in the Europe unit are forecast to be consistent with the second quarter as lower selling prices are largely offset by reduced raw material costs. The company expects lower results in the Tubular segment in the third quarter due to reduced selling prices.
Moreover, U.S. Steel continues to progress toward completing the transaction with Nippon Steel Corporation later this year.
<h3>Price Performance</h3>
The company&#39;s shares have rallied 67.6% in the past year compared with the industry&#39;s 12.6% decline.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/51/73182.jpg?v=823218616" />
Image Source: Zacks Investment Research
<h3>Zacks Rank &amp; Key Picks</h3>
X currently carries a Zacks Rank #5 (Strong Sell).
Some better-ranked stocks in the Basic Materials space are Kronos Worldwide, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kro#NYSE">KRO</a>), Ashland Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ash#NYSE">ASH</a>) and Hecla Mining Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hl#NYSE">HL</a>), each sporting a Zacks Rank #1 (Strong Buy).
Kronos is expected to report second-quarter results on Aug 7. The Zacks Consensus Estimate for KRO&#39;s second-quarter earnings is pegged at 21 cents. The company&#39;s shares have rallied roughly 33% in the past year.&nbsp;
Ashland is slated to report fiscal third-quarter results on Aug 6. The Zacks Consensus Estimate for ASH&#39;s third-quarter earnings is pegged at $1.47. The company&#39;s shares have gained roughly 7% in the past year.&nbsp;
Hecla is slated to report second-quarter results on Aug 6. The Zacks Consensus Estimate for Hecla&#39;s second-quarter earnings is pegged at a penny per share. The stock has gained nearly 2% in the past year.
<a href="https://www.zacks.com/stock/news/2315087/u-s-steel-s-x-earnings-and-revenues-surpass-estimates-in-q2?cid=CS-BENZ-FT-analyst_blog|earnings_article-2315087">To read this article on Zacks.com click here.</a>

Penny Stocks

Small Cap

U.S. Steel's Earnings and Revenues Surpass Estimates in Q2

DuPont de Nemours, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dd#NYSE">DD</a>) registered a profit from continuing operations of $176 million or 40 cents per share in the second quarter of 2024. In the year-ago quarter, the company recorded a profit of $269 million or 55 cents per share.
Barring one-time items, earnings came in at 97 cents per share in the reported quarter, topping the Zacks Consensus Estimate of 85 cents.
DuPont&#39;s net sales reached $3,171 million, marking a 2% year-over-year increase and surpassing the Zacks Consensus Estimate of $3,035.8 million. Organic sales remained flat in the quarter, as a 2% increase in volume was counterbalanced by a 2% decrease in price.
The rise in volume was primarily driven by broad-based growth in the electronics sector. However, this was partially offset by year-over-year declines in industrial businesses, particularly in Water Solutions in China and medical packaging within Safety Solutions.
<div class="chart_embed">
<h3>DuPont de Nemours, Inc. Price, Consensus and EPS Surprise</h3>
<img alt="DuPont de Nemours, Inc. Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/75/1722428726.png" style="height:265px; width:576px" title="" />
DuPont de Nemours, Inc. price-consensus-eps-surprise-chart | DuPont de Nemours, Inc. Quote
</div>
<h3>Segment Highlights</h3>
The company&#39;s Electronics &amp; Industrial segment reported net sales of $1,508 million in the quarter, a 15% year-over-year increase, surpassing our estimate of $1,408.4 million. Organic sales grew 8%, driven by a 10% rise in volume, which was partially offset by a 2% decrease in price.
Semiconductor Technologies saw a more than 20% increase in organic sales, fueled by continued recovery in semiconductor demand, advancements in AI-driven technology and higher volumes for OLED materials due to new product launches. Interconnect Solutions experienced low-teens growth in organic sales, with mid-teens volume gains reflecting a broad-based recovery in consumer electronics. Industrial Solutions faced a low-double-digit decline in organic sales, primarily due to ongoing channel inventory destocking in the Kalrez and biopharma markets.
The Water &amp; Protection unit recorded net sales of $1,391 million, a 7% decrease from the previous year, surpassing our estimate of $1,359.5 million. The decline was due to a 6% drop in organic sales and a 1% currency headwind, with organic sales reflecting a 4% decrease in volume and a 2% decrease in price.
Safety Solutions saw high-single-digit declines in organic sales, mainly due to volume reductions and continued channel inventory destocking for medical packaging products. Water Solutions also experienced high-single-digit declines in organic sales, driven by lower volumes from distributor inventory destocking in China. Conversely, Shelter Solutions achieved low-single-digit growth in organic sales, supported by improved demand in construction markets compared to the prior year.
<h3>Financials</h3>
DuPont had cash and cash equivalents of $1,503 million at the end of the quarter, down around 70% year over year. Long-term debt was $7,168 million, down about 7.8% year over year.
The company generated operating cash flow from continuing operations of $527 million in the second quarter.
<h3>Outlook</h3>
DuPont has revised its financial outlook for the year, raising the company&#39;s projections for net sales, operating EBITDA and adjusted EPS. The company now anticipates full-year 2024 net sales to be $12.45 billion, operating EBITDA to be $3.085 billion and adjusted EPS to be $3.75 per share, based on the midpoint of the updated guidance ranges.
For the third quarter of 2024, DuPont expects a return to year-over-year organic sales growth, led by the Electronics &amp; Industrial segment. Sales and earnings growth in the Water &amp; Protection segment are anticipated to begin in the fourth quarter. The company forecasts net sales of $3.2 billion, operating EBITDA of $815 million and adjusted EPS of $1.03 for the third quarter.
<h3>Price Performance</h3>
DuPont&#39;s shares have increased 4.4% in a year versus a 10.4% decline in the&nbsp;industry.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/b2/72962.jpg?v=2088085748" />
Image Source: Zacks Investment Research
<h3>Zacks Rank &amp; Key Picks</h3>
DuPont currently has a Zacks Rank #4 (Sell).
Some better-ranked stocks in the Basic Materials space are Hecla Mining Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hl#NYSE">HL</a>), Franco-Nevada Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fnv#NYSE">FNV</a>) and Ashland Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ash#NYSE">ASH</a>). Hecla and Franco-Nevada sport a Zacks Rank #1 (Strong Buy) and Ashland carries a Zacks Rank #2 (Buy) at present.
The Zacks Consensus Estimate for Hecla&#39;s current-year earnings is pegged at 5 cents, indicating a rise of 600% from year-ago levels. The consensus estimate for HL&#39;s earnings has increased 25% in the past 60 days.The stock has gained nearly 2.2% in the past year. It will report second-quarter results on Aug 6.
The Zacks Consensus Estimate for FNV&#39;s current-year earnings is pegged at $3.27. The consensus estimate for FNV&#39;s earnings has increased by 3% in the past 60 days. FNV beat the consensus estimate in the last four quarters, with the average earnings surprise being 10.5%. It is scheduled to release second-quarter results on Aug 13.
The Zacks Consensus Estimate for ASH&#39;s current-year earnings is pegged at $4.56, indicating a year-over-year rise of 12%. ASH&#39;s earnings beat the Zacks Consensus Estimate in three of the last four quarters while matching it once, the average earnings surprise being 5.3%. The company&#39;s shares have increased 5.4% in the past year. It is slated to report fiscal third-quarter results on Aug 6.
<a href="https://www.zacks.com/stock/news/2313038/dupont-s-dd-earnings-and-revenues-top-estimates-in-q2?cid=CS-BENZ-FT-analyst_blog|earnings_article-2313038">To read this article on Zacks.com click here.</a>

DuPont's Earnings and Revenues Top Estimates in Q2

Investors interested in Basic Materials stocks should always be looking to find the best-performing companies in the group. Has Aris Mining Corporation (AMEX:ARMN) been one of those stocks this year? Let&#39;s take a closer look at the stock&#39;s year-to-date performance to find out.
Aris Mining Corporation is one of 238 individual stocks in the Basic Materials sector. Collectively, these companies sit at #5 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Aris Mining Corporation is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for ARMN&#39;s full-year earnings has moved 5.4% higher. This means that analyst sentiment is stronger and the stock&#39;s earnings outlook is improving.
Based on the latest available data, ARMN has gained about 31.5% so far this year. In comparison, Basic Materials companies have returned an average of -1.1%. This means that Aris Mining Corporation is performing better than its sector in terms of year-to-date returns.
Another Basic Materials stock, which has outperformed the sector so far this year, is Ashland (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ash#NYSE">ASH</a>). The stock has returned 14.7% year-to-date.
Over the past three months, Ashland&#39;s consensus EPS estimate for the current year has increased 5.4%. The stock currently has a Zacks Rank #1 (Strong Buy).
Looking more specifically, Aris Mining Corporation belongs to the Mining - Gold industry, a group that includes 37 individual stocks and currently sits at #33 in the Zacks Industry Rank. On average, this group has gained an average of 23.4% so far this year, meaning that ARMN is performing better in terms of year-to-date returns.
In contrast, Ashland falls under the Chemical - Specialty industry. Currently, this industry has 33 stocks and is ranked #51. Since the beginning of the year, the industry has moved -17.7%.
Aris Mining Corporation and Ashland could continue their solid performance, so investors interested in Basic Materials stocks should continue to pay close attention to these stocks.
<a href="https://www.zacks.com/stock/news/2304361/are-basic-materials-stocks-lagging-aris-mining-corporation-armn-this-year?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_1-2304361">To read this article on Zacks.com click here.</a>

ARMN

Are Basic Materials Stocks Lagging Aris Mining Corporation This Year?

BMO Capital analyst John McNulty maintains Ashland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) with a Market Perform and raises the price target from $97 to $105.

BMO Capital Maintains Market Perform on Ashland, Raises Price Target to $105

The transaction is expected to close in the calendar&nbsp;third quarter&nbsp;2024, subject to the satisfaction of customary closing conditions.
Ashland&#39;s nutraceuticals business supplies a broad portfolio of active ingredients and formulation aids to nutritional product companies, as well as custom formulation and contract manufacturing capabilities for the nutrition market, from four production facilities in New Jersey and Utah in the United States, and Tamaulipas, Mexico.

Asset Sales

Ashland Signs Definitive Deal To Sell Nutraceuticals Business To Turnspire Capital Partners; No Terms Disclosed

JP Morgan analyst Jeffrey Zekauskas maintains Ashland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) with a Underweight and raises the price target from $88 to $90.

JP Morgan Maintains Underweight on Ashland, Raises Price Target to $90

UBS analyst Joshua Spector maintains Ashland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) with a Buy and raises the price target from $114 to $116.

UBS Maintains Buy on Ashland, Raises Price Target to $116

3 analysts have expressed a variety of opinions on Ashland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $116.0, a high estimate of $126.00, and a low estimate of $110.00. This upward trend is evident, with the current average reflecting a 15.62% increase from the previous average price target of $100.33.
<img src="https://www.benzinga.com/files/images/story/2024/1714575677_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Ashland. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Buy</td>
<td>$110.00</td>
<td>$101.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$112.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Laurence Alexander</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$126.00</td>
<td>$100.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Ashland. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Ashland compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into Ashland's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ASH/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Ashland analyst ratings.</a>
<h2>Unveiling the Story Behind Ashland</h2>
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. Ashland includes only U.S. and Canada in its North America designation and includes Europe, the Middle East and Africa in its Europe designation.
<h3>Unraveling the Financial Story of Ashland</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Decline in Revenue: Over the 3 months period, Ashland faced challenges, resulting in a decline of approximately -9.9% in revenue growth as of 31 December, 2023. This signifies a reduction in the company's top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Ashland's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 5.5%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Ashland's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 0.85%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Ashland's ROA stands out, surpassing industry averages. With an impressive ROA of 0.44%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Ashland's debt-to-equity ratio is below the industry average at 0.48, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: Simplified</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

3 Analysts Have This To Say About Ashland

Mizuho analyst John Roberts maintains Ashland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) with a Buy and raises the price target from $101 to $110.

Mizuho Maintains Buy on Ashland, Raises Price Target to $110

Ashland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) reported quarterly earnings of $1.27 per share which beat the analyst consensus estimate of $1.14 by 11.4 percent. This is a 11.19 percent decrease over earnings of $1.43 per share from the same period last year. The company reported quarterly sales of $575.000 million which beat the analyst consensus estimate of $574.638 million by 0.06 percent. This is a 4.64 percent decrease over sales of $603.000 million the same period last year.

Ashland Q2 2024 Adj EPS $1.27 Beats $1.14 Estimate, Sales $575.000M Beat $574.638M Estimate

Analyst David Begleiter of Deutsche Bank maintained a Buy rating on Ashland (ASH – Research Report), with a price target of $100.00. David Begleite...

Ashland: A Buy Rating Amidst Volume Growth and Strong EBITDA Prospects

Ashland declares $0.405 dividend

Argus Research analyst Bill Selesky maintained a Buy rating on Ashland (ASH – Research Report) yesterday. The company's shares closed yesterday at ...

Ashland (ASH) Gets a Buy from Argus Research

Eminence Capital buys Dynatrace, exits Discover Financial, others in Q2

Dividend Champion, Contender, And Challenger Highlights: Week Of August 25

Dividend Champion, Contender, And Challenger Highlights: Week Of September 8

Michael Sison, an analyst from Wells Fargo, maintained the Buy rating on Ashland (ASH – Research Report). The associated price target remains the s...

Ashland's Positive Long-Term Outlook Amid Current Demand Softness: A Buy Rating by Michael Sison

New small-cap buy and sell ideas for Oppenheimer's 50/50 list

ClearBridge Mid Cap Strategy Q3 2024 Commentary

In a report released yesterday, Michael Sison from Wells Fargo maintained a Buy rating on Ashland (ASH – Research Report), with a price target of $...

Comments

Ashland

Ashland (ASH) Opciones

Ashland (NYSE:ASH) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL